|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.240 EUR | -0.40% |
|
+8.77% | -15.65% |
| 07/07 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| 29/06 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.40% | +8.77% | -2.75% | +15.89% | 12.09M | ||
| -2.47% | -6.72% | +44.19% | +156.44% | 1,054B | ||
| -1.83% | -5.28% | +61.41% | +58.33% | 621B | ||
| -1.27% | -3.95% | +27.71% | +79.83% | 438B | ||
| -1.12% | -3.68% | +26.89% | +20.58% | 325B | ||
| -1.73% | -3.45% | +26.95% | +44.09% | 281B | ||
| -1.95% | -13.92% | +15.96% | +19.76% | 262B | ||
| -1.45% | -2.37% | -27.87% | -39.87% | 219B | ||
| -1.41% | -3.37% | +19.75% | +56.40% | 195B | ||
| -0.88% | -4.45% | +16.24% | +68.79% | 163B | ||
| Average | -1.50% | -0.66% | +20.85% | +48.02% | 355.62B | |
| Weighted average by Cap. | -1.84% | -1.69% | +33.09% | +76.97% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















